BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,520.00
+40.00 (0.89%)
Apr 8, 2026, 3:07 PM KST
Market Cap41.59B +1.1%
Revenue (ttm)75.80B +1.3%
Net Income-4.90B
EPS-527.00
Shares Out9.28M
PE Ration/a
Forward PEn/a
Dividend90.91 (2.03%)
Ex-Dividend DateDec 29, 2025
Volume8,148
Average Volume11,427
Open4,480.00
Previous Close4,480.00
Day's Range4,460.00 - 4,630.00
52-Week Range3,827.27 - 6,030.00
Beta0.85
RSI37.70
Earnings DateMar 27, 2026

About BCWORLD PHARM.

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analges... [Read more]

Sector Healthcare
Founded 1980
Employees 280
Stock Exchange KOSDAQ
Ticker Symbol 200780
Full Company Profile

Financial Performance

In 2025, BCWORLD PHARM.'s revenue was 75.80 billion, an increase of 1.32% compared to the previous year's 74.81 billion. Losses were -4.90 billion, 10.5% more than in 2024.

Financial Statements